Buscar
Congreso SOLACI
HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

Ver Categoría

Chronic Ischemic cardiopathy

Severity of Lesions Assessed by FFR in Coronary Disease: Is It Associated with Major Events?

In patients with coronary disease, the prognosis depends on the extent and reversibility of myocardial ischemia. Whether...
solaci -
Ver más
Chronic Ischemic cardiopathy

Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?

The use of both internal thoracic (mammary) arteries for myocardial revascularization surgery might improve long-term outcomes, compared...
solaci -
Ver más
Chronic Ischemic cardiopathy

Right vs. Left Transradial Access for Coronary Procedures

Courtesy of Dr. Guillermo Migliaro. Coronary angiography and angioplasty via transradial approach are associated with a significant reduction...
solaci -
Ver más
Chronic Ischemic cardiopathy

Coronary Lesions After TAVR: Severity May Be Modified

Courtesy of Dr. Carlos Fava. Between 40% and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary...
solaci -
Ver más
Chronic Ischemic cardiopathy

Post PCI High Sensitivity Troponin Elevation: No Prognostic Value

The prognostic value of high sensitivity troponin elevation after elective PCI in patients with or without elevated...
solaci -
Ver más
Chronic Ischemic cardiopathy

FUTURE: Mortality Increase in the FFR Arm, Real or Casual?

The FUTURE study, testing the utility of functional revascularization by measuring the fractional flow reserve (FFR), was halted...
solaci -
Ver más
Chronic Ischemic cardiopathy

Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of...
solaci -
Ver más
Chronic Ischemic cardiopathy

Non-Cardiac Surgery with Incomplete Revascularization, Associated to Events

This study presented at the American Heart Association Scientific Sessions 2016 and simultaneously published in the Journal of...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

OPTION Trial: Left Atrial Appendage Closure

Dr. Carlos Fava - 0
Atrial fibrillation ablation is a valid strategy. However, reoccurrence is frequent in these cases, often with asymptomatic presentation. Anticoagulation with warfarin has proven effective in...

TRI-SPA Study: Tricuspid Edge-to-Edge Treatment

Dr. Carlos Fava - 0
Tricuspid regurgitation (TR) is a condition associated with high morbidity and mortality. Currently, surgery is the recommended treatment; however, it carries a high complication...

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad